List of Drugs Linked to Dementia

Anticholinergics: are drugs that block the action of acetylcholine - Acetylcholine is a neurotransmitter, or a chemical messenger. It transfers signals between certain cells to affect how your body functions.

​

**Antidepressants:**
- Amitriptyline (Elavil)
- Clomipramine (Anafranil)
- Desipramine (Norpramin)
- Doxepin (Sinequan)
- Imipramine (Tofranil)
- Nortriptyline (Aventyl)

**Antipsychotics:**
- Aripiprazole (Abilify)
- Chlorpromazine (Thorazine)
- Clozapine (Clozaril)
- Flupenthixol (Depixol)
- Fluphenazine (Modecate)
- Haloperidol (Haldol)
- Loxapine (Adasuve)
- Olanzapine (Zyprexa)
- Paliperidone (Invega)
- Perphenazine (Trilafon)
- Pimozide (Orap)
- Quetiapine (Seroquel)
- Risperidone (Risperdal)
- Thiothixene (Navane)
- Trifluoperazine (Stelazine)
- Ziprasidone (Geodon)
- Zuclopenthixol (Clopixol)

**Antiparkinsonians:**

- Benztropine (Cogentin)
- Biperiden (Akineton)
- Trihexyphenidyl (Artane)

**Antiepileptics:**

- Carbamazepine (Tegretol)
- Oxcarbazepine (Trileptal)

**Bladder control medications:**

- Darifenacin (Enablex)
- Oxybutynin (Ditropan)
- Solifenacin (Vesicare)
- Tolterodine (Detrol)
- Trospium (Sanctura)

**Antihistamines:**
- Brompheniramine (Dimaphen DM)
- Chlorpheniramine (ChlorTrimeton)
- Clemastine (Dayhist Allergy)
- Cyproheptadine (Periactin)
- Dexchlorpheniramine (Polmon)
- Diphenhydramine (Benadryl)
- Dimenhydrinate (Dramamine)
- Hydroxyzine (Vistaril)
- Pyrilamine (Codimal DM)

​

**Sleep Aids:**
- Doxylamine (Vicks NyQuil)

​

**Other Anticholinergics:**
- Methscopolamine (Pamine)
- Propantheline (Pro-Banthine)

**Benzodiazepines:**
- Alprazolam (Xanax)
- Chlordiazepoxide (Librium)
- Clonazepam (Klonopin)
- Clorazepate (Tranxene)
- Diazepam (Valium)
- Estazolam (Prosom)
- Flurazepam (Dalmane)
- Lorazepam (Ativan)
- Nitrazepam (Mogadon)
- Oxazepam (Serax)
- Quazepam (Doral)
- Temazepam (Restoril)
- Triazolam (Halcion)

**Other Drugs:**
-- Antimuscarinics
-- Chemotherapy drugs
-- Corticosteroids
-- High blood pressure medications
-- Motion sickness medications
-- Pain medications
-- Statins

________________________________________________________________________________

### Impact of Medications on Dementia Risk

**1. Mechanism of Action:** Benzodiazepines (BZDs) are a class of medications primarily prescribed for their anxiolytic (anti-anxiety), sedative, hypnotic, muscle relaxant, and anticonvulsant properties. They enhance the effect of the neurotransmitter gamma-aminobutyric acid (GABA) in the brain, leading to central nervous system depression.

**2. Short-term Cognitive Effects:** In the short term, benzodiazepines are known to cause impairments in cognitive function, including memory and attention. These effects are typically more pronounced with higher doses and longer durations of use.

**3. Memory Impairment:** Long-term use of benzodiazepines has been associated with memory impairment and cognitive decline in some studies. Chronic use, especially at higher doses, may lead to difficulties in learning and memory retention.

- **Anticholinergics and Dementia:** Research indicates a strong link between anticholinergic drugs and an increased risk of dementia. These include certain antidepressants, antipsychotics, antiepileptics, and bladder control medications.
- **Benzodiazepines and Dementia:** Benzodiazepines, prescribed for anxiety and insomnia, are associated with a substantial rise in dementia risk, particularly when used in high doses or for extended periods.​

Benzodiazepines, prescribed for anxiety and insomnia, are associated with a substantial rise in dementia risk, particularly when used in high doses or for extended periods.
 

Other Medications:
     Various other drugs, including some chemotherapy agents, corticosteroids, high blood pressure medications, and statins, have been observed to contribute to memory loss and cognitive decline.

Chemo Brain vs. Dementia:
"Chemo brain" refers to cognitive and memory problems associated with cancer treatments, which, unlike dementia, are often reversible. It’s crucial to distinguish between the two as they have different implications and management strategies.

     To reduce the risk of medication-induced dementia, it’s important to review all medications with a healthcare provider, including over-the-counter drugs. Geriatricians can offer valuable insights and suggest alternative treatments that may be safer for seniors.
________________________________________________________________________________

​​

#### Foods and Supplements that Improve Cognitive Function

**Blueberries:** Blueberry supplementation has been shown to improve memory in older adults, offering potential protection against Alzheimer's due to their high antioxidant content.

**Strawberries:** Consumption of strawberries is associated with a 24% reduced risk of Alzheimer's and dementia, attributed to their antioxidant properties.

**Cherries:** Cherries contain anthocyanidins, which protect the brain from damage caused by free radicals, and have anti-inflammatory properties.

**Rosemary:** Fresh rosemary, when grown in frequently used rooms, can be used in foods and teas to support cognitive health.

**Cinnamon, Sage, Turmeric, and Cumin:** These spices help break up brain plaque and reduce inflammation, potentially mitigating memory issues.

**Coconut Oil:** Regular consumption of cold-pressed virgin coconut oil or extra virgin olive oil, possibly infused with CBD, has been suggested to support brain health.

**Fatty Fish:** Fish rich in omega-3 fatty acids, such as salmon, mackerel, and sardines, support cognitive function.

**Nuts:** Various nuts, including walnuts and pecans, contain nutrients that are beneficial for brain health.

**Eggs and Folic Acid:** Eggs provide brain-healthy nutrients, and folic acid supports cognitive function.

**Dark Chocolate:** Chocolate with 70% or higher cocoa content contains flavonoids that improve blood flow to the brain.

**Avocados:** Daily consumption of avocados may improve cognitive function in older adults.

**Cruciferous Vegetables:** Broccoli, cauliflower, and Brussels sprouts contain folate and carotenoids that support cognitive health.

**Beans and Legumes:** These foods are high in folate, iron, magnesium, and potassium, supporting overall brain function.

**Seeds:** Pumpkin, chia, flax, and sunflower seeds contain B vitamins that protect against cognitive decline.

**Vitamin B-12 Complex and Vitamin E:** These vitamins, especially when consumed through food, are protective against Alzheimer's disease.

#### Natural Treatments and Medicinal Plants

**Cannabis:** Certain strains of Cannabis sativa high in alpha-pinene may improve cognitive thinking, while those high in myrcene may help with sleep.

**Psilocybin:** This compound may stimulate neurogenesis, provoke neuroplastic changes, and reduce neuroinflammation, offering potential therapeutic benefits for Alzheimer's.

**LSD:** Studies suggest that LSD may have therapeutic potential for Alzheimer's by enhancing cognitive function.

**Amanita Muscaria:** Historically used to enhance cognitive abilities, Amanita muscaria may offer benefits for cognitive health.

**Lion's Mane Mushroom:** Daily use of Lion's Mane has been reported to improve cognitive function and stimulate nerve growth factor.

________________________________________________________________________________

Why is Alzheimer's called Type 3 diabetes? The Brain Docs

Alzheimer's - Diabetes of the Brain Caused by Fructose?

Is Fructose a Driver of Alzheimer’s Disease? | Dr. Richard Johnson & Dr. Rob Lustig

Alzheimer's Disease: The EARLY WARNING SIGNS & How To Reverse It | Richard Johnson & Dale Bredesen

Alzheimer's Disease Starts in the Liver - Dr. Berg

Prof. Raphael Mechoulam: Father of THC & CBD on Cannabis for Alzheimer's

Dr. Ethan Russo, MD: Treating Alzheimer's & Other Dementia w/ Full Spectrum Cannabis

Dale Bredesen, MD: The First Survivors of Alzheimer's: How Patients Recovered Life and Hope

How to Cure Alzheimers and Dementia - Paul Stamets

Dr Joe Dispenza 'How to prevent/heal Alzheimer & Dementia Pt 6/7

Alzheimer's Disease & the Endocannabinoid System

Alzheimer’s Disease and Medical Cannabis

Cannabis, a Miracle Drug with Polyvalent Therapeutic Utility: Preclinical and Clinical-Based Evidence

Cannabis and Alzheimer’s Disease: What the Research Shows​

Cannabis-based medicine to be tested in Alzheimer's trial

Israeli Researcher Dedi Meiri On Cannabis, Alzheimer’s And Dementia​

A Review on Studies of Marijuana for Alzheimer’s Disease – Focusing on CBD, THC

CBD reduces plaque, improves cognition in model of familial Alzheimer's​

Emerging Promise of Cannabinoids for the Management of Pain and Associated Neuropathological Alterations in Alzheimer’s Disease

________________________________________________________________________________

     Research into the relationship between opioid use and Alzheimer's disease (AD) suggests that opioid receptors may play a role in the disease's pathology, although direct causation is not yet conclusively established.

     Opioid receptors, specifically the μ (mu), κ (kappa), and δ (delta) receptors, are involved in various physiological processes, including pain modulation, stress response, and cognitive functions. These receptors are found in brain regions like the hippocampus and cortex, which are significantly impacted by AD. The presence of opioid receptors in these areas has led researchers to explore their potential role in Alzheimer's pathology【†source】.

     There is evidence that opioid receptors are involved in the regulation of amyloid-beta (Aβ) plaques, a hallmark of AD. Opioid receptor activation can affect various neurotransmitter systems, such as glutamatergic and serotonergic pathways, which are known to be dysregulated in Alzheimer's disease. This interaction might influence the formation and deposition of Aβ plaques【†source】【†source】.

     Chronic opioid use is known for its potential to cause dependency and other side effects, its direct link to causing Alzheimer's disease remains unclear. Opioid receptors do overlap in their distribution with regions affected by AD, and opioid receptor activity might modulate disease progression through complex mechanisms involving neurotransmitter systems and Aβ plaque dynamics【†source】.

​​

     Recent research indicates that compounds found in cannabis, specifically cannabinoids like THC and CBD, show potential in reducing Alzheimer's disease symptoms by targeting amyloid-beta plaques in the brain. These plaques are protein deposits that accumulate between nerve cells, disrupting communication and contributing to cognitive decline.

​​

     A study from the Salk Institute demonstrated that cannabinoids could help remove amyloid-beta plaques from brain cells. The research highlighted that these compounds not only reduced inflammation but also enabled the cells to survive and function better under conditions that would otherwise be toxic due to the plaques【†source】.

​​

     Another study published in **Neuroscience News** supports these findings, suggesting that cannabinoids can reduce inflammation and amyloid-beta protein levels in neurons, potentially improving brain health and function【†source】.

​

     Moreover, cannabinoids' anti-inflammatory properties are critical because inflammation is a significant contributor to Alzheimer's progression. By reducing inflammation, cannabinoids might help protect brain cells from further damage and maintain healthier neural connections, which are crucial for clear thinking and memory.

     

     For more detailed information on these studies, you can refer to the sources from ScienceDaily and Neuroscience News: ScienceDaily - Neuroscience News

​​

### Natural Substances and Neurogenesis in Alzheimer's Disease

#### Cannabis and Neurogenesis
Cannabis, particularly its compounds like cannabidiol (CBD), has shown promising potential in promoting neurogenesis and reducing the plaque associated with Alzheimer's disease. Research indicates that CBD can ameliorate cognitive functions by upregulating proteins such as IL-33 and TREM2, which are involved in the immune response and brain health. This upregulation helps in reducing amyloid-beta plaques, a hallmark of Alzheimer's, thereby improving cognitive functions in animal models【†source】【†source】.

#### Mushrooms and Neurogenesis
Mushrooms, especially varieties like Lion’s Mane, contain compounds that may support neurogenesis and cognitive function. Studies suggest that Hericium erinaceus (Lion's Mane) stimulates the production of nerve growth factor (NGF), which is crucial for the maintenance and regeneration of neurons. This could potentially contribute to the repair of neural pathways damaged by Alzheimer's disease.

#### Comparison with Synthetic Drugs
Synthetic drugs for Alzheimer's, such as cholinesterase inhibitors and NMDA receptor antagonists, primarily focus on managing symptoms rather than addressing the underlying causes like amyloid plaque build-up and neurodegeneration. Natural substances like cannabis and mushrooms offer a holistic approach by promoting neurogenesis and reducing neuroinflammation, which can help in the removal of plaques and the restoration of neural connections.

### Conclusion

     In my professional opinion, based on personal experience recovering from Alzheimer's, I firmly believe that the use of opioids and benzodiazepines (such as Xanax) significantly contributed to the progression of the disease. While synthetic drugs play a crucial role in symptomatic treatment, natural substances like cannabis and mushrooms offer additional benefits by promoting neurogenesis and reducing amyloid plaques. For me, the combination of cannabis and mushrooms was crucial in successfully clearing the plaque from my synapses, which had accumulated due to opioid, Xanax, and other drug use associated with dementia, as well as poor lifestyle habits (such as high fructose corn syrup). This therapy documented below allowed me to fully recover from Alzheimer's. Bradley F. Reed
     
      For more detailed information, refer to the following sources:
- [ScienceDaily on CBD and Alzheimer's]
- [Neuroscience News on Cannabinoids and Alzheimer's]

____________________________________________________________________________________

Despite Lack of Evidence, 10 States Allow Medical Marijuana for Alzheimer’s

The Experiments Revealing How Marijuana Could Treat Dementia

Cannabis as a Multifaceted Treatment Approach to Alzheimer’s Disease

ACTIVE INGREDIENT IN CANNABIS PROTECTS AGING BRAIN CELLS

The therapeutic potential of cannabis in Alzheimer's disease

Alzheimer’s Disease pathology

Alzheimer's Disease & the Endocannabinoid System

Alzheimer's Disease – Marijuana Doctors | Online Medical

CBD for Alzheimer’s: Treatment Reduces Plaque Buildups in the Brain That Causes Disease

The Potential Therapeutic Effects of THC on Alzheimer's Disease

A Review on Studies of Marijuana for Alzheimer's Disease

Alzheimer’s Disease and Medical Cannabis

Big Alzheimer’s research roadblock: Federal government

2 accused of false Alzheimer's diagnoses charged with fraud

Shocking SCIENTIFIC FRAUD allegations against major medical research
 
Looking Into Psychedelics for Alzheimer's Research
 
Unveiling the Therapeutic Potentials of Mushroom Bioactive Compounds in Alzheimer’s Disease​

Lsd for the treatment of alzheimer's disease

Lion’s mane mushrooms can protect against dementia and Alzheimer’s

US20090274720A1 - Anti-dementia substance from hericium

Amanita muscaria extract potentiates production

________________________________________________________________________________

#### Research Highlights

1. **Endocannabinoid System and Alzheimer's:** - **Study Findings** The endocannabinoid system regulates brain function. Research indicates that cannabinoids can reduce neuroinflammation and oxidative stress, potentially slowing Alzheimer's progression.- **Clinical Trials**: Ongoing trials are exploring the efficacy of cannabis-based treatments in managing Alzheimer's symptoms.

2. **Patented Treatments (US6630507B1):** - **Patent Overview** This patent covers the use of cannabinoids as neuroprotectants, offering potential therapeutic benefits for neurodegenerative diseases like Alzheimer's. The patented method involves using specific cannabinoids to protect brain cells and improve cognitive function.   

​

     Comprehensive information on cannabis and mushrooms for Alzheimer's disease and addiction recovery includes documented case studies and research findings:

1. **Lion's Mane Mushroom and Cognitive Improvement:**
Lion's Mane mushroom (Hericium erinaceus) enhances cognitive function, especially in mild cognitive impairment. A Japanese study showed elderly participants who took Lion's Mane supplements for 16 weeks had improved cognitive function compared to a placebo group, with no adverse effects reported​ (BioUpdate)​​ (ScienceDaily)​.

2. **Cannabis and Alzheimer's Disease:**
Cannabis, particularly THC, may reduce amyloid-beta levels and slow neurodegeneration, potentially benefiting Alzheimer's patients by alleviating symptoms like agitation​ (BioUpdate)​.

3. **Alzheimer's Treatment with Natural Remedies:**
Natural remedies, including medicinal mushrooms and cannabis, improve cognitive function and well-being in Alzheimer's patients. Personalized regimens incorporating dietary changes, Lion's Mane mushroom supplementation, and controlled cannabis use have shown significant symptom reduction​ (BioUpdate)​.

4. **Addiction Recovery and Natural Remedies:**
Cannabis and medicinal mushrooms support addiction recovery by managing withdrawal symptoms and reducing cravings, contributing to improved outcomes and sustained sobriety​ (BioUpdate)​.

     Further Reading and Resources
     For detailed case studies and clinical trials, you can explore the following sources:

University of Queensland's Study on Lion's Mane Mushroom:

Mushrooms magnify memory by boosting nerve growth
Research on Lion's Mane Clinical Trial:

Improving Effects of the Mushroom Yamabushitake (Hericium erinaceus) on Mild Cognitive Impairment

      These resources provide a solid foundation for understanding the therapeutic potential of natural remedies in treating Alzheimer's disease and supporting addiction recovery.
____________________________________________________________________________________

​

### 1. Genetic Factors
- **APOE-e4 Gene:** The presence of the APOE-e4 allele is the strongest known genetic risk factor for late-onset Alzheimer's disease. Individuals carrying this allele have an increased risk of developing Alzheimer's compared to those with the more common APOE-e3 allele.
- **Other Genetic Mutations** Mutations in genes such as APP, PSEN1, and PSEN2 are associated with early-onset familial Alzheimer's disease. These mutations lead to abnormal processing of amyloid precursor protein, resulting in the accumulation of amyloid-beta plaques in the brain.

### 2. Amyloid Plaques and Tau Tangles
- **Amyloid-Beta Plaques:** These are abnormal clumps of protein that accumulate outside neurons. The amyloid hypothesis suggests that the accumulation of amyloid-beta plaques in the brain is a primary cause of Alzheimer's disease.
- **Tau Tangles:** Neurofibrillary tangles are twisted fibers of tau protein that build up inside neurons. Tau tangles disrupt the normal functioning of neurons and are strongly associated with Alzheimer's progression.

### 3. Inflammation and Immune Response
- **Neuroinflammation:** Chronic inflammation in the brain is believed to contribute to Alzheimer's disease. Microglia, the brain's immune cells, can become overactive and release inflammatory cytokines, which may damage neurons and exacerbate disease progression.
- **Immune System Dysfunction:** Recent studies suggest that the immune system may play a critical role in Alzheimer's. For example, the complement system, part of the immune system, has been implicated in synaptic loss and neurodegeneration in Alzheimer's patients.

### 4. Metabolic Factors and Insulin Resistance
- **Type 2 Diabetes:** There is a well-established link between type 2 diabetes and an increased risk of Alzheimer's disease. Insulin resistance and hyperinsulinemia may contribute to the development of Alzheimer's by impairing brain glucose metabolism.
- **Metabolic Syndrome:** Conditions like obesity, hypertension, and dyslipidemia are also associated with an increased risk of Alzheimer's.

### 5. Vascular Factors
- **Cardiovascular Health:** Poor cardiovascular health, including conditions such as atherosclerosis, hypertension, and heart disease, is linked to an increased risk of Alzheimer's. Vascular damage can impair blood flow to the brain, contributing to cognitive decline.
- **Cerebral Small Vessel Disease:** This condition affects the small blood vessels in the brain and can lead to white matter lesions and microbleeds, which are associated with cognitive impairment and Alzheimer's disease.

### 6. Lifestyle and Environmental Factors
- **Diet:** Diets high in saturated fats, refined sugars, and processed foods are associated with an increased risk of Alzheimer's. Conversely, diets rich in fruits, vegetables, whole grains, lean proteins, and healthy fats (like the Mediterranean diet) are associated with a lower risk.
- **Physical Activity:** Regular physical exercise is associated with a reduced risk of Alzheimer's. Exercise improves cardiovascular health, reduces inflammation, and promotes neurogenesis (the formation of new neurons).
- **Smoking and Alcohol:** Both smoking and excessive alcohol consumption are linked to an increased risk of Alzheimer's. Quitting smoking and moderating alcohol intake can reduce this risk.
- **Cognitive Engagement:** Mental stimulation through activities like reading, playing games, and socializing is associated with a lower risk of Alzheimer's.

### 7. Exposure to Toxins and Infections
- **Toxins:** Exposure to environmental toxins such as heavy metals, pesticides, and air pollution has been implicated in Alzheimer's disease. These toxins can cause oxidative stress and neuroinflammation.
- **Infections:** Some research suggests that infections, particularly chronic bacterial or viral infections, might contribute to Alzheimer's. For instance, the herpes simplex virus (HSV-1) and certain types of bacteria have been found in higher levels in the brains of Alzheimer's patients.

### 8. Fructose Consumption
- **High Fructose Corn Syrup:** There is growing evidence that high consumption of fructose, particularly from high fructose corn syrup found in many processed foods, may contribute to the development of Alzheimer's. Fructose can lead to insulin resistance, metabolic syndrome, and increased inflammation, all of which are risk factors for Alzheimer's.

### 9. Medications
- **Anticholinergic Drugs:** Long-term use of medications with anticholinergic properties has been associated with an increased risk of dementia. These drugs block acetylcholine, a neurotransmitter important for memory and learning.
- **Benzodiazepines:** These medications, often prescribed for anxiety and insomnia, have been linked to an increased risk of dementia when used long-term or in high doses.

### 10. Hormonal Changes
- **Menopause:** The decline in estrogen levels during menopause has been linked to an increased risk of Alzheimer's in women. Estrogen has neuroprotective effects, and its reduction may contribute to cognitive decline.